Nuclear Medicine Market Report 2026
Nuclear Medicine Market Global Report 2026 Market Report Infographic Image
Item added to cart!

Published : February 2026

Pages : 200

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF
Purchase This Report

Nuclear Medicine Market Report 2026

Global Outlook – By Type (Diagnostic, Therapeutic), By Application (Cardiology, Lymphoma, Thyroid, Neurology, Oncology, Other Applications), By End-User (Hospitals And Clinics, Diagnostic Centers, Other End-Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Nuclear Medicine Market Overview

• Nuclear Medicine market size has reached to $10.18 billion in 2025

• Expected to grow to $17.13 billion in 2030 at a compound annual growth rate (CAGR) of 10.7%

• Growth Driver: Cardiovascular Disease And Cancer Surge Drive Growth In The Nuclear Medicine Market

• Market Trend: Product Innovation Drives Advancements In The Nuclear Medicine Market

North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Nuclear Medicine Market?

Nuclear medicine refers to a specialised area of radiology that uses radioactive material inside the body to inspect the overall health condition of the concerned patient.

The main types of nuclear medicine are diagnostic and therapeutic. A diagnostic is an examination to identify a person's distinct areas of strength and weakness to identify a condition, disease, or illness. The applications involved cardiology, lymphoma, thyroid, neurology, oncology, and other applications. The end-users included hospitals and clinics, diagnostic centers, and other end-users.

Nuclear Medicine Market Global Report 2026 Market Report bar graph

What Is The Nuclear Medicine Market Size and Share 2026?

The nuclear medicine market size has grown rapidly in recent years. It will grow from $10.18 billion in 2025 to $11.4 billion in 2026 at a compound annual growth rate (CAGR) of 11.9%. The growth in the historic period can be attributed to limited access to nuclear imaging equipment, high cost of radiopharmaceuticals, lack of trained personnel, limited hospital and diagnostic center infrastructure, low patient awareness.

What Is The Nuclear Medicine Market Growth Forecast?

The nuclear medicine market size is expected to see rapid growth in the next few years. It will grow to $17.13 billion in 2030 at a compound annual growth rate (CAGR) of 10.7%. The growth in the forecast period can be attributed to rising demand for advanced diagnostic and therapeutic procedures, increasing government initiatives for cancer and cardiac care, growth in hospital and diagnostic center adoption, technological advancements in radiopharmaceuticals and imaging, increasing patient awareness and healthcare expenditure. Major trends in the forecast period include rising adoption of diagnostic imaging techniques, increasing use of therapeutic radiopharmaceuticals, growing demand for pet and spect scans, rising focus on oncology and cardiology applications, increasing implementation in hospitals and diagnostic centers.

Customer representative image Book your 30 minutes free consultation with our research experts

Global Nuclear Medicine Market Segmentation

1) By Type: Diagnostic, Therapeutic

2) By Application: Cardiology, Lymphoma, Thyroid, Neurology, Oncology, Other Applications

3) By End-User: Hospitals And Clinics, Diagnostic Centers, Other End-Users

Subsegments:

1) By Diagnostic: Single Photon Emission Computed Tomography (SPECT), Positron Emission Tomography (PET), Gamma Cameras

2) By Therapeutic: Radiopharmaceuticals For Targeted Therapy, Beta Emitters, Alpha Emitters, Radiosynovectomy Agents

What Is The Driver Of The Nuclear Medicine Market?

The increase in constancy and prevalence of cardiovascular disease (CVD) and cancer are expected to propel the growth of the nuclear medicine market going forward. Cardiovascular diseases (CVDs) are a group of heart and blood vessel disorders, and cancer is a disease in which cells grow out of control and spread to other body parts. Nuclear cardiac imaging can help diagnose cardiac diseases more quickly. Nuclear medicine therapy is a method to treat cancer that might be used with or after other therapy options, such as surgery and chemotherapy. As a result, the growing constancy and prevalence of cardiovascular disease and cancer increase the demand for the nuclear medicine market. For instance, in January 2023, according to the American Cancer Society Inc., a US-based non-profit health group, 1,958,310 new cancer cases are expected to be diagnosed in the US, an increase compared to more than 1,918,030 new cancer cases in 2022. Therefore, the growing constancy and prevalence of cardiovascular diseases and cancer are driving the nuclear medicine industry.

Key Players In The Global Nuclear Medicine Market

Major companies operating in the nuclear medicine market are Bracco Imaging S.P.A., Lantheus Medical Imaging Inc., NTP Radioisotopes SOC Ltd., Eckert & Ziegler Group, Jubilant Pharma LLC, Australian Nuclear Science & Technology Organisation, Cardinal Health Inc., GE Healthcare Technologies Inc., Curium Pharma, Advanced Accelerator Applications USA Inc., Nordion Inc., The Institute for Radioelements, Eczacibasi-Monrol Nuclear Products Co., Siemens Healthineers AG, Cambridge Isotope Laboratories Inc., Bayer AG, Triad Isotopes Inc., Mallinckrodt Pharmaceuticals plc, PharmaLogic Holdings Corp., Institute of Isotopes Co. Ltd., Sinotau Pharmaceuticals Limited, Isotopia Molecular Imaging Limited, SHINE Medical Technologies Inc., JSC Isotope Inc., NorthStar Medical Radioisotopes LLC, Global Medical Solutions LLC

Global Nuclear Medicine Market Trends and Insights

Major companies operating in the nuclear medicine market are focusing on developing innovative solutions, such as nuclear medicine cyclotrons, to enhance the production of radiopharmaceuticals and improve diagnostic imaging capabilities. Nuclear medicine Cyclotrons are specialized particle accelerators that produce radioactive isotopes for medical imaging and therapy by directing high-energy particles at target materials, enabling the synthesis of radiopharmaceuticals used in procedures like positron emission tomography (PET). For instance, in January 2024, GE Healthcare China, a US-based medical technology company, launched its first batch of cyclotrons on December 1, 2023, at the Chengdu Tianfu International Bio-Town. These advanced particle accelerators are crucial for nuclear medicine, enabling the production of medical isotopes used in molecular imaging and therapeutic applications. This initiative aims to establish a comprehensive ecosystem for nuclear medicine, enhancing capabilities in early disease detection and personalized treatment.

Need data on a specific region in this market?

What Are Latest Mergers And Acquisitions In The Nuclear Medicine Market?

In December 2023, Bristol Myers Squibb, a US-based biopharmaceutical company, acquired RayzeBio, Inc. for approximately $ 4.1 billion. Through this acquisition, BMS aims to expand its nuclear medicine oncology portfolio by integrating RayzeBio’s actinium-based radiopharmaceutical platform and advancing the development of first-in-class targeted therapies. RayzeBio, Inc. is a US-based clinical-stage company specializing in targeted radiopharmaceutical therapeutics for solid tumors.

Regional Outlook

North America was the largest region in the nuclear medicine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Nuclear Medicine Market?

The nuclear medicine market consists of sales of bone density scanning, cardiac PET perfusion, cardiac PET sarcoid. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Nuclear Medicine Market Report 2026?

The nuclear medicine market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the nuclear medicine industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Nuclear Medicine Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $11.4 billion
Revenue Forecast In 2035 $17.13 billion
Growth Rate CAGR of 11.9% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Type, Application, End-User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Bracco Imaging S.P.A., Lantheus Medical Imaging Inc., NTP Radioisotopes SOC Ltd., Eckert & Ziegler Group, Jubilant Pharma LLC, Australian Nuclear Science & Technology Organisation, Cardinal Health Inc., GE Healthcare Technologies Inc., Curium Pharma, Advanced Accelerator Applications USA Inc., Nordion Inc., The Institute for Radioelements, Eczacibasi-Monrol Nuclear Products Co., Siemens Healthineers AG, Cambridge Isotope Laboratories Inc., Bayer AG, Triad Isotopes Inc., Mallinckrodt Pharmaceuticals plc, PharmaLogic Holdings Corp., Institute of Isotopes Co. Ltd., Sinotau Pharmaceuticals Limited, Isotopia Molecular Imaging Limited, SHINE Medical Technologies Inc., JSC Isotope Inc., NorthStar Medical Radioisotopes LLC, Global Medical Solutions LLC
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Nuclear Medicine Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Nuclear Medicine Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Nuclear Medicine Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Nuclear Medicine Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.1.3 Artificial Intelligence & Autonomous Intelligence

4.1.4 Digitalization, Cloud, Big Data & Cybersecurity

4.1.5 Industry 4.0 & Intelligent Manufacturing

4.2. Major Trends

4.2.1 Rising Adoption Of Diagnostic Imaging Techniques

4.2.2 Increasing Use Of Therapeutic Radiopharmaceuticals

4.2.3 Growing Demand For Pet And Spect Scans

4.2.4 Rising Focus On Oncology And Cardiology Applications

4.2.5 Increasing Implementation In Hospitals And Diagnostic Centers

5. Nuclear Medicine Market Analysis Of End Use Industries

5.1 Hospitals And Clinics

5.2 Diagnostic Centers

5.3 Oncology Centers

5.4 Cardiology Clinics

5.5 Research Institutes

6. Nuclear Medicine Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Nuclear Medicine Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Nuclear Medicine PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Nuclear Medicine Market Size, Comparisons And Growth Rate Analysis

7.3. Global Nuclear Medicine Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Nuclear Medicine Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Nuclear Medicine Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Nuclear Medicine Market Segmentation

9.1. Global Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Diagnostic, Therapeutic

9.2. Global Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Cardiology, Lymphoma, Thyroid, Neurology, Oncology, Other Applications

9.3. Global Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals And Clinics, Diagnostic Centers, Other End-Users

9.4. Global Nuclear Medicine Market, Sub-Segmentation Of Diagnostic, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Single Photon Emission Computed Tomography (SPECT), Positron Emission Tomography (PET), Gamma Cameras

9.5. Global Nuclear Medicine Market, Sub-Segmentation Of Therapeutic, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Radiopharmaceuticals For Targeted Therapy, Beta Emitters, Alpha Emitters, Radiosynovectomy Agents

10. Nuclear Medicine Market Regional And Country Analysis

10.1. Global Nuclear Medicine Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Nuclear Medicine Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Nuclear Medicine Market

11.1. Asia-Pacific Nuclear Medicine Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Nuclear Medicine Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Nuclear Medicine Market

12.1. China Nuclear Medicine Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Nuclear Medicine Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Nuclear Medicine Market

13.1. India Nuclear Medicine Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Nuclear Medicine Market

14.1. Japan Nuclear Medicine Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Nuclear Medicine Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Nuclear Medicine Market

15.1. Australia Nuclear Medicine Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Nuclear Medicine Market

16.1. Indonesia Nuclear Medicine Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Nuclear Medicine Market

17.1. South Korea Nuclear Medicine Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Nuclear Medicine Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Nuclear Medicine Market

18.1. Taiwan Nuclear Medicine Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Nuclear Medicine Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Nuclear Medicine Market

19.1. South East Asia Nuclear Medicine Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Nuclear Medicine Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Nuclear Medicine Market

20.1. Western Europe Nuclear Medicine Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Nuclear Medicine Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Nuclear Medicine Market

21.1. UK Nuclear Medicine Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Nuclear Medicine Market

22.1. Germany Nuclear Medicine Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Nuclear Medicine Market

23.1. France Nuclear Medicine Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Nuclear Medicine Market

24.1. Italy Nuclear Medicine Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Nuclear Medicine Market

25.1. Spain Nuclear Medicine Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Nuclear Medicine Market

26.1. Eastern Europe Nuclear Medicine Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Nuclear Medicine Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Nuclear Medicine Market

27.1. Russia Nuclear Medicine Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Nuclear Medicine Market

28.1. North America Nuclear Medicine Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Nuclear Medicine Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Nuclear Medicine Market

29.1. USA Nuclear Medicine Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Nuclear Medicine Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Nuclear Medicine Market

30.1. Canada Nuclear Medicine Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Nuclear Medicine Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Nuclear Medicine Market

31.1. South America Nuclear Medicine Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Nuclear Medicine Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Nuclear Medicine Market

32.1. Brazil Nuclear Medicine Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Nuclear Medicine Market

33.1. Middle East Nuclear Medicine Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Nuclear Medicine Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Nuclear Medicine Market

34.1. Africa Nuclear Medicine Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Nuclear Medicine Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Nuclear Medicine Market Regulatory and Investment Landscape

36. Nuclear Medicine Market Competitive Landscape And Company Profiles

36.1. Nuclear Medicine Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Nuclear Medicine Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Nuclear Medicine Market Company Profiles

36.3.1. Bracco Imaging S.P.A. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Lantheus Medical Imaging Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. NTP Radioisotopes SOC Ltd. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Eckert & Ziegler Group Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Jubilant Pharma LLC Overview, Products and Services, Strategy and Financial Analysis

37. Nuclear Medicine Market Other Major And Innovative Companies

Australian Nuclear Science & Technology Organisation, Cardinal Health Inc., GE Healthcare Technologies Inc., Curium Pharma, Advanced Accelerator Applications USA Inc., Nordion Inc., The Institute for Radioelements, Eczacibasi-Monrol Nuclear Products Co., Siemens Healthineers AG, Cambridge Isotope Laboratories Inc., Bayer AG, Triad Isotopes Inc., Mallinckrodt Pharmaceuticals plc, PharmaLogic Holdings Corp., Institute of Isotopes Co. Ltd.

38. Global Nuclear Medicine Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Nuclear Medicine Market

40. Nuclear Medicine Market High Potential Countries, Segments and Strategies

40.1 Nuclear Medicine Market In 2030 - Countries Offering Most New Opportunities

40.2 Nuclear Medicine Market In 2030 - Segments Offering Most New Opportunities

40.3 Nuclear Medicine Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Nuclear Medicine Market, Overview Of Key Products - Product Examples
  • Table 2: Global Nuclear Medicine Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Nuclear Medicine Market, Supply Chain Analysis
  • Table 4: Global Nuclear Medicine Market, Major Raw Material Providers
  • Table 5: Global Nuclear Medicine Market, Major Resource Providers
  • Table 6: Global Nuclear Medicine Market, Major Manufacturers (Suppliers)
  • Table 7: Global Nuclear Medicine Market, Major Distributors And Channel Partners
  • Table 8: Global Nuclear Medicine Market, Key Technologies & Future Trends
  • Table 9: Global Nuclear Medicine Market, Major Trends
  • Table 10: Global Nuclear Medicine Market, Major End Users
  • Table 11: Global Nuclear Medicine Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Nuclear Medicine Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Nuclear Medicine Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Nuclear Medicine Market - TAM, US$ Billion, 2025
  • Table 15: Global Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Nuclear Medicine Market, Sub-Segmentation Of Diagnostic, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Nuclear Medicine Market, Sub-Segmentation Of Therapeutic, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Nuclear Medicine Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Nuclear Medicine Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Asia-Pacific, Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Asia-Pacific, Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Asia-Pacific, Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: China, Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: China, Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: China, Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: India, Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: India, Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: India, Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: Japan, Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: Japan, Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Japan, Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Australia, Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Australia, Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Australia, Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Indonesia, Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Indonesia, Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Indonesia, Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: South Korea, Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: South Korea, Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: South Korea, Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: Taiwan, Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: Taiwan, Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Taiwan, Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: South East Asia, Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: South East Asia, Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: South East Asia, Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: Western Europe, Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: Western Europe, Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Western Europe, Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: UK, Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: UK, Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: UK, Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: Germany, Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: Germany, Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: Germany, Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: France, Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: France, Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: France, Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: Italy, Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: Italy, Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: Italy, Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Spain, Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Spain, Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Spain, Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Eastern Europe, Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Eastern Europe, Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Eastern Europe, Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Russia, Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Russia, Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Russia, Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: North America, Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: North America, Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: North America, Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: USA, Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: USA, Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: USA, Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: Canada, Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: Canada, Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: Canada, Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: South America, Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: South America, Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: South America, Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: Brazil, Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: Brazil, Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: Brazil, Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Middle East, Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Middle East, Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Middle East, Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Africa, Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Africa, Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Africa, Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Global Nuclear Medicine Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 95: Global Nuclear Medicine Market - Company Scoring Matrix
  • Table 96: Bracco Imaging S.P.A. Financial Performance
  • Table 97: Lantheus Medical Imaging Inc. Financial Performance
  • Table 98: NTP Radioisotopes SOC Ltd. Financial Performance
  • Table 99: Eckert & Ziegler Group Financial Performance
  • Table 100: Jubilant Pharma LLC Financial Performance
  • Table 101: Global Nuclear Medicine Market, Competitive Benchmarking (In USD Billions)
  • Table 102: Global Nuclear Medicine Market, Competitive Dashboard
  • Table 103: Global Nuclear Medicine Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 104: Global, Nuclear Medicine Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030
  • Table 105: Global, Nuclear Medicine Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030
  • Table 106: Global, Nuclear Medicine Market Size Gain ($ Billion), Segmentation By End-User, 2025 – 2030

List Of Figures

    Figure 1: Global Nuclear Medicine Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Nuclear Medicine Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Nuclear Medicine Market, Supply Chain Analysis
  • Figure 4: Global Nuclear Medicine Market, Major Raw Material Providers
  • Figure 5: Global Nuclear Medicine Market, Major Resource Providers
  • Figure 6: Global Nuclear Medicine Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Nuclear Medicine Market, Major Distributors And Channel Partners
  • Figure 8: Global Nuclear Medicine Market, Key Technologies & Future Trends
  • Figure 9: Global Nuclear Medicine Market, Major Trends
  • Figure 10: Global Nuclear Medicine Market, Major End Users
  • Figure 11: Global Nuclear Medicine Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Nuclear Medicine Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Nuclear Medicine Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Nuclear Medicine Market - TAM, US$ Billion, 2025
  • Figure 15: Global Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Nuclear Medicine Market, Sub-Segmentation Of Diagnostic, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Nuclear Medicine Market, Sub-Segmentation Of Therapeutic, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Nuclear Medicine Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Nuclear Medicine Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Asia-Pacific, Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Asia-Pacific, Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Asia-Pacific, Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: China, Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: China, Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: China, Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: India, Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: India, Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: India, Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: Japan, Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: Japan, Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Japan, Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Australia, Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Australia, Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Australia, Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Indonesia, Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Indonesia, Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Indonesia, Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: South Korea, Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: South Korea, Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: South Korea, Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: Taiwan, Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: Taiwan, Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Taiwan, Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: South East Asia, Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: South East Asia, Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: South East Asia, Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: Western Europe, Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: Western Europe, Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Western Europe, Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: UK, Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: UK, Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: UK, Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: Germany, Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: Germany, Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: Germany, Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: France, Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: France, Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: France, Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: Italy, Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: Italy, Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: Italy, Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Spain, Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Spain, Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Spain, Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Eastern Europe, Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Eastern Europe, Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Eastern Europe, Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Russia, Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Russia, Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Russia, Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: North America, Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: North America, Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: North America, Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: USA, Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: USA, Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: USA, Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: Canada, Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: Canada, Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: Canada, Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: South America, Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: South America, Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: South America, Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: Brazil, Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: Brazil, Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: Brazil, Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Middle East, Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Middle East, Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Middle East, Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Africa, Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Africa, Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Africa, Nuclear Medicine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Global Nuclear Medicine Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 95: Global Nuclear Medicine Market - Company Scoring Matrix
  • Figure 96: Bracco Imaging S.P.A. Financial Performance
  • Figure 97: Lantheus Medical Imaging Inc. Financial Performance
  • Figure 98: NTP Radioisotopes SOC Ltd. Financial Performance
  • Figure 99: Eckert & Ziegler Group Financial Performance
  • Figure 100: Jubilant Pharma LLC Financial Performance
  • Figure 101: Global Nuclear Medicine Market, Competitive Benchmarking (In USD Billions)
  • Figure 102: Global Nuclear Medicine Market, Competitive Dashboard
  • Figure 103: Global Nuclear Medicine Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 104: Global, Nuclear Medicine Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030
  • Figure 105: Global, Nuclear Medicine Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030
  • Figure 106: Global, Nuclear Medicine Market Size Gain ($ Billion), Segmentation By End-User, 2025 – 2030

Frequently Asked Questions

The Nuclear Medicine Market Report 2026 market was valued at $10.18 billion in 2025, increased to $11.4 billion in 2026, and is projected to reach $17.13 billion by 2030. request a sample here

The expected CAGR for the Nuclear Medicine Market Report 2026 market during the forecast period 2025–2030 is 10.7%. request a sample here

Major growth driver of the market includes: Cardiovascular Disease And Cancer Surge Drive Growth In The Nuclear Medicine Market in the Nuclear Medicine Market Report 2026 market. For further insights on this market, request a sample here

The nuclear medicine market covered in this report is segmented –
1) By Type: Diagnostic, Therapeutic
2) By Application: Cardiology, Lymphoma, Thyroid, Neurology, Oncology, Other Applications
3) By End-User: Hospitals And Clinics, Diagnostic Centers, Other End-Users Subsegments:
1) By Diagnostic: Single Photon Emission Computed Tomography (SPECT), Positron Emission Tomography (PET), Gamma Cameras
2) By Therapeutic: Radiopharmaceuticals For Targeted Therapy, Beta Emitters, Alpha Emitters, Radiosynovectomy Agents
request a sample here

Major trend in this market includes: Product Innovation Drives Advancements In The Nuclear Medicine Market For further insights on this market, request a sample here.

Major companies operating in the Nuclear Medicine Market Report 2026 market are Major companies operating in the nuclear medicine market are Bracco Imaging S.P.A., Lantheus Medical Imaging Inc., NTP Radioisotopes SOC Ltd., Eckert & Ziegler Group, Jubilant Pharma LLC, Australian Nuclear Science & Technology Organisation, Cardinal Health Inc., GE Healthcare Technologies Inc., Curium Pharma, Advanced Accelerator Applications USA Inc., Nordion Inc., The Institute for Radioelements, Eczacibasi-Monrol Nuclear Products Co., Siemens Healthineers AG, Cambridge Isotope Laboratories Inc., Bayer AG, Triad Isotopes Inc., Mallinckrodt Pharmaceuticals plc, PharmaLogic Holdings Corp., Institute of Isotopes Co. Ltd., Sinotau Pharmaceuticals Limited, Isotopia Molecular Imaging Limited, SHINE Medical Technologies Inc., JSC Isotope Inc., NorthStar Medical Radioisotopes LLC, Global Medical Solutions LLC request a sample here.

North America was the largest region in the nuclear medicine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nuclear medicine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts